Involvement of pro-apoptotic and anti-apoptotic factors in the early development of the human pituitary gland

Histology and Histopathology

Volumn 23, Issue 10, 2008, Pages 1259-1268

  Saraga Babic, Mirna ^a   Bazina, Mirna ^a   Vukojevic, Katarina ^a,b   Bocina, Ivana ^c   Stefanovic, Vedran ^d  

^a UNIVERSITY OF SPLIT   (Croatia)

^b UNIVERSITY OF MOSTAR   (Bosnia and Herzegovina)

^c UNIVERSITY OF SPLIT   (Croatia)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bcl 2; Caspase 3; Human embryos; P 53; Pituitary gland

Indexed keywords

CASPASE 3; PROTEIN BCL 2; PROTEIN P53; APOPTOSIS REGULATORY PROTEIN; CASP3 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADENOHYPOPHYSIS; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS FUNCTION; MESENCHYME; MORPHOGENESIS; NEUROHYPOPHYSIS; ENZYMOLOGY; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; METABOLISM; NICK END LABELING; PRENATAL DEVELOPMENT;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CELL DIFFERENTIATION; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MORPHOGENESIS; PITUITARY GLAND; PITUITARY GLAND, POSTERIOR; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 54449084326     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Anilikumar T.V., Sarraf C.E. and Alison M.R. (1992). The biology and pathology of programmed cell death (apoptosis). Vet. Hum. Toxicol. 34, 251-254.
2. Asa S.L. and Ezzat S. (2004). Molecular basis of pituitary development and cytogenesis. Front. Horm. Res. 32, 1-19.
3. Bazina M., Stefanovic V., Bozanic D. and Saraga-Babic M. (2007). Ultrastructural and immunohistochemical characteristics of developing human pituitary gland. Acta. Histochem. 109, 366-376.
4. Bozanic D. and Saraga-Babic M. (2004). Cell proliferation during the early stages of human eye development. Anat. Embryol. (Berl). 208, 381-388.
5. Burgess R., Lunyak V. and Rosenfeld M. (2002). Signaling and transcriptional control of pituitary development. Curr. Opin. Genet. Dev. 12, 534-539.
6. Carev D., Krnic D., Saraga M., Sapunar D. and Saraga-Babic M. (2006). Role of mitotic, pro-apoptotic and anti-apoptotic factors in human kidney development. Pediatr. Nephrol. 21, 627-636.
7. Carlson B.M. (2004). Human embriology and developmental biology. Mosby Inc. Philadelphia. pp 233-277.
8. Chen C.J. (2001). Suprasellar and infrasellar craniopharyngioma with a persistent craniopharyngeal canal: Case report and review of the literature. Neuroradiology 43, 760-762.
9. Dasen J.S. and Rosenfeld M.G. (2001). Signaling and transcriptional mechanisms in pituitary development. Annu. Rev. Neurosci. 24, 327-355.
10. Deutsch H., Kothbauer K., Persky M., Epstein F.J. and Jallo G.I. (2001). Infrasellar craniopharyngiomas: Case report and review of the literature. Skull Base 11, 121-128.
11. Dubois P.M., El Amraoui A. and Heritier A.G. (1997). Development and differentiation of pituitary cells. Microsc. Res. Tech. 39, 98-113.
12. Ericson J., Norlin S., Jessell T.M. and Edlund T. (1998). Integrated fgf and bmp signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 125, 1005-1015.
13. Falavigna A. and Kraemer J.L. (2001). Infrasellar craniopharyngioma: Case report. Arq. Neuropsiquiatr. 59, 424-430.
14. Fujita E., Urase K., Egashira J., Miho Y., Isahara K., Uchiyama Y., Isoai A., Kumagai H., Kuida K., Motoyama N. and Momoi T. (2000). Detection of caspase-9 activation in the cell death of the bcl-x-deficient mouse embryo nervous system by cleavage sites-directed antisera. Brain. Res. Dev. Brain. Res. 122, 135-147. Green V.L., White M.C., Hipkin L.J., Jeffereys R.V., Foy P.M. and Atkin S.L. (1997). Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas. Eur. J. Endocrinol. 136, 382-387.
15. Hengartner M.O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
16. Huppertz B., Frank H.G. and Kaufmann P. (1999). The apoptosis cascade - morphological and immunohistochemical methods for its visualization. Anat. Embryol. (Berl). 200, 1-18.
17. James T.N. (1994). Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90, 556-573.
18. Kachhara R., Nair S., Gupta A.K., Radhakrishnan V.V. and Bhattacharya R.N. (2002). Infrasellar craniopharyngioma mimicking a clival chordoma: A case report. Neurol. India 50, 198-200.
19. Kapranos N., Kontogeorgos G., Horvath E. and Kovacs K. (2004). Morphology, molecular regulation and significance of apoptosis in pituitary adenomas. Front. Horm. Res. 32, 217-234.
20. Ketola I., Toppari J., Vaskivuo T., Herva R., Tapanainen J.S. and Heikinheimo M. (2003). Transcription factor gata-6, cell proliferation, apoptosis, and apoptosis-related proteins bcl-2 and bax in human fetal testis. J. Clin. Endocrinol. Metab. 88, 1858-1865.
21. Kim H.S., Hwang K.K., Seo J.W., Kim S.Y., Oh B.H., Lee M.M. and Park Y.B. (2000). Apoptosis and regulation of bax and bcl-x proteins during human neonatal vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 20, 957-963.
22. Klocke B.J., Latham C.B., D'sa C. and Roth K.A. (2002). P53 deficiency fails to prevent increased programmed cell death in the bcl-x(l)-deficient nervous system. Cell. Death Differ. 9, 1063-1068.
23. Kontogeorgos G. (2005). Classification and pathology of pituitary tumors. Endocrine 28, 27-35.
24. Kontogeorgos G. (2006). Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83, 179-188.
25. Koseki C., Herzlinger D. and Al-awqati Q. (1992). Apoptosis in metanephric development. J. Cell Biol. 119, 1327-1333.
26. Kulig E., Jin L., Qian X., Horvath E., Kovacs K., Stefaneanu L., Scheithauer B.W. and Lloyd R.V. (1999). Apoptosis in nontumorous and neoplastic human pituitaries: Expression of the bcl-2 family of proteins. Am. J. Pathol. 154, 767-774.
27. Lichovsky V., Kolar Z., Murray P., Hlobilkova A., Cernochova D., Pospisilova E., Vojtesek B. and Nenutil R. (1998). Differences in p53 and bcl-2 expression in relation to cell proliferation during the development of human embryos. Mol. Pathol. 51, 131-137.
28. Lichovsky V., Erdosova B., Punkt K. and Zapletal M. (1999). Expression of bcl-2 in the developing kidney of human embryos and fetuses qualitative and quantitative study. Acta Univ. Palacki. Olomuc. Fac. Med. 142, 61-64.
29. Miosge N., Schneider W., Gotz W. and Herken R. (1997). The oncoproteins c-erb-b2, c-fos and the tumour suppressor protein p53 in human embryos and fetuses. Anat. Embryol. (Berl). 195, 345-352.
30. Moore K.L. and Persaud T.V.N. (1993). The developing human: Clinically oriented embryology. W.B. Saunders Company. Philadelphia. pp 405-409.
31. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Negishi I., Senju S., Zhang Q. and Fujii S. (1995). Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Science 267, 1506-1510.
32. Mullis P.E. (2000). Transcription factors in pituitary gland development and their clinical impact on phenotype. Horm. Res. 54, 107-119.
33. O'Rahilly R. and Gardner E. (1971). The timing and sequence of events in the development of the human nervous system during the embryonic period proper. Z. Anat. Entwicklungsgesch. 134, 1-12.
34. Ozer E., Canda M.S., Ulukus C., Guray M. and Erbayraktar S. (2003). Expression of bcl-2, bax and p53 proteins in pituitary adenomas: An immunohistochemical study. Tumori 89, 54-59.
35. Prabhu V.C. and Brown H.G. (2005). The pathogenesis of craniopharyngiomas. Childs Nerv. Syst. 21, 622-627.
36. Prochazkova J., Lichnovsky V., Kylardova D., Erdosova B. and Vranka P. (2004). Involvement of p53 and bcl-2 family proteins in regulating programmed cell death and proliferation in human embryogenesis. Gen. Physiol. Biophys. 23, 209-229.
37. Raetzman L.T., Ward R. and Camper S.A. (2002). Lhx4 and prop1 are required for cell survival and expansion of the pituitary primordia. Development 129, 4229-4239.
38. Reynolds E.S. (1963). The use of lead citrate at high ph as an electronopaque stain in electron microscopy. J. Cell Biol. 17, 208-212.
39. Rezvani M., Barrans J.D., Dai K.S. and Liew C.C. (2000). Apoptosis-related genes expressed in cardiovascular development and disease: An est approach. Cardiovasc. Res. 45, 621-629.
40. Rizzoti K. and Lovell-Badge R. (2005). Early development of the pituitary gland: Induction and shaping of rathke's pouch. Rev. Endocr. Metab. Disord. 6, 161-172.
41. Rosenfeld M.G., Briata P., Dasen J., Gleiberman A.S., Kioussi C., Lin C., O'Connell S.M., Ryan A., Szeto D.P. and Treier M. (2000). Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo. Recent. Prog. Horm. Res. 55, 1-13.
42. Sambaziotis D., Kapranos N. and Kontogeorgos G. (2003). Correlation of bcl-2 and bax with apoptosis in human pituitary adenomas. Pituitary 6, 127-133.
43. Sbrogna J.L., Barresi M.J. and Karlstrom R.O. (2003). Multiple roles for hedgehog signaling in zebrafish pituitary development. Dev. Biol. 254, 19-35.
44. Sheng H.Z., Moriyama K., Yamashita T., Li H., Potter S.S., Mahon K.A. and Westphal H. (1997). Multistep control of pituitary organogenesis. Science 278, 1809-1812.
45. Takuma N., Sheng H.Z., Furuta Y., Ward J.M., Sharma K., Hogan B.L., Pfaff S.L., Westphal H., Kimura S. and Mahon K.A. (1998). Formation of rathke's pouch requires dual induction from the diencephalon. Development 125, 4835-4480.
46. Taniguchi Y., Yasutaka S., Kominami R. and Shinohara H. (2002a). Mitoses of thyrotrophs contribute to the proliferation of the rat pituitary gland during the early postnatal period. Anat. Embryol. (Berl). 206, 67-72.
47. Taniguchi Y., Yasutaka S., Kominami R. and Shinohara H. (2002b). Proliferation and differentiation of rat anterior pituitary cells. Anat. Embryol. (Berl). 206, 1-11.
48. Vilovic K., Ilijic E., Glamoclija V., Kolic K., Bocina I., Sapunar D. and Saraga-Babic M. (2006). Cell death in developing human spinal cord. Anat. Embryol. (Berl). 211, 1-9.
49. Vojtisek B., Bartek J., Midgley C.A. and Lane D.P. (1992). An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods 151, 237-244.
50. Zhao Y., Morales D.C., Hermesz E., Lee W.K., Pfaff S.L. and Westphal H. (2006). Reduced expression of the lim-homeobox gene lhx3 impairs growth and differentiation of rathke's pouch and increases cell apoptosis during mouse pituitary development. Mech. Dev. 123, 605-613.